UBS Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.5M | Sell |
|
|||||
|
2025
Q2 | $44.9M | Buy |
|
|||||
|
2025
Q1 | $40.8M | Buy |
|
|||||
|
2024
Q4 | $60.3M | Buy |
|
|||||
|
2024
Q3 | $12.7M | Buy |
|
|||||
|
2024
Q2 | $7.22M | Sell |
|
|||||
|
2024
Q1 | $12M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $3.79M | Buy |
|
|||||
|
2023
Q2 | $2.29M | Buy |
|
|||||
|
2023
Q1 | $12.9K | Sell |
|
|||||
|
2022
Q4 | $5.88M | Buy |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $513K | Sell |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $1.08M | Sell |
|
|||||
|
2021
Q3 | $3.09M | Buy |
|
|||||
|
2021
Q2 | $2.43M | Sell |
|
|||||
|
2021
Q1 | $2.28M | Buy |
|
|||||
|
2020
Q4 | $1.81M | Buy |
|
|||||
|
2020
Q3 | $36K | Buy |
|